MAINTENANCE OF REMISSION WITH TOFACITINIB IN PATIENTS WITH ULCERATIVE COLITIS: FINAL RESULTS OF A SUBPOPULATION ANALYSIS FROM AN OPEN-LABEL, LONG-TERM EXTENSION STUDY, OCTAVE OPEN

被引：0
|
作者：
Colombel, Jean Frederic
Osterman, Mark T.
Ibanez, Patricio
Vermeire, Severine
Irving, Peter M.
Gardiner, Sean M.
Connelly, Susan B.
Mundayat, Rajiv
Lawendy, Nervin
Su, Chinyu
Reinisch, Walter
机构：
来源：
GASTROENTEROLOGY | 2021年 / 160卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
649
引用
收藏
页码：S125 / S126
页数：2
相关论文
共 50 条
  • [1] Maintenance of remission with tofacitinib in patients with ulcerative colitis: Updated results of a subpopulation analysis from an open-label, long-term extension study, OCTAVE Open
    Colombel, J. F.
    Osterman, M. T.
    Ibanez, P.
    Thorpe, A. J.
    Zhang, H.
    Lawendy, N.
    Su, C.
    Reinisch, W.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S098 - S099
  • [2] MAINTENANCE OF REMISSION WITH TOFACITINIB IN PATIENTS WITH ULCERATIVE COLITIS: UPDATED RESULTS OF A SUBPOPULATION ANALYSIS FROM AN OPEN-LABEL, LONG-TERM EXTENSION STUDY, OCTAVE OPEN
    Colombel, Jean Frederic
    Osterman, Mark T.
    Ibanez, Patricio
    Thorpe, Andrew J.
    Zhang, Haiying
    Lawendy, Nervin
    Su, Chinyu
    Reinisch, Walter
    [J]. GASTROENTEROLOGY, 2020, 158 (06) : S1198 - S1199
  • [3] Maintenance of Remission with Tofacitinib in Patients With Ulcerative Colitis: Subpopulation Analysis from an Open-Label, Long-Term Extension Study
    Jean-Frederic, Colombel
    Walter, Reinisch
    Mark, Osterman T.
    Andrew, Thorpe J.
    Chudy, Nduaka, I
    Zhang Haiying
    Nervin, Lawendy
    Gary, Friedman S.
    Su Chinyu
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S4 - S4
  • [4] Maintenance of Remission With Tofacitinib in Patients With Ulcerative Colitis: Subpopulation Analysis From an Open-Label, Long-Term Extension Study
    Colombel, Jean-Frederic
    Reinisch, Walter
    Osterman, Mark T.
    Thorpe, Andrew J.
    Nduaka, Chudy I.
    Zhang, Haiying
    Lawendy, Nervin
    Friedman, Gary S.
    Su, Chinyu
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S389 - S390
  • [5] Persistence of Tofacitinib Treatment in Patients With Ulcerative Colitis Who Entered the Open-Label, Long-Term Extension Study, OCTAVE OPEN in Remission or With a Clinical Response
    Panaccione, Remo
    Abreu, Maria T.
    Lazariciu, Irina
    Mundayat, Rajiv
    Lawendy, Nervin
    Salese, Leonardo
    Woolcott, John C.
    Sands, Bruce E.
    Chaparro, Maria
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S351 - S351
  • [6] Safety and efficacy of tofacitinib for treatment of ulcerative colitis: final analysis of OCTAVE Open, an open-label, long-term extension study with up to 7.0 years of treatment
    Sandborn, William J.
    Lawendy, Nervin
    Danese, Silvio
    Su, Chinyu
    Loftus, Edward V., Jr.
    Hart, Ailsa
    Dotan, Iris
    Damiao, Aderson O. M. C.
    Judd, Donna T.
    Guo, Xiang
    Modesto, Irene
    Wang, Wenjin
    Panes, Julian
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (04) : 464 - 478
  • [7] Persistence of treatment in patients with ulcerative colitis who responded to tofacitinib therapy: Data from the open-label, long-term extension study, OCTAVE open
    Panaccione, Remo
    Abreu, Maria T.
    Lazariciu, Irina
    Mundayat, Rajiv
    Lawendy, Nervin
    Salese, Leonardo
    Woolcott, John C.
    Sands, Bruce E.
    Chaparro, Maria
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (12) : 1534 - 1544
  • [8] Persistence of Tofacitinib Treatment in Patients With Ulcerative Colitis Who Entered the Open-Label, Long-Term Extension Study, OCTAVE OPEN Without a Clinical Response
    Panaccione, Remo
    Abreu, Maria T.
    Lazariciu, Irina
    Mundayat, Rajiv
    Lawendy, Nervin
    Salese, Leonardo
    Woolcott, John C.
    Sands, Bruce E.
    Chaparro, Maria
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S351 - S352
  • [9] Sustained improvement in health-related quality of life outcomes in patients with Ulcerative Colitis with long-term tofacitinib treatment in the open-label extension study, OCTAVE Open
    Biedermann, L.
    Dubinsky, M. C.
    Vermeire, S.
    Fellmann, M.
    Gardiner, S.
    Hur, P.
    Mundayat, R.
    Panes, J.
    Rubin, D. T.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I317 - I319
  • [10] TOFACITINIB, AN ORAL JAK INHIBITOR, IN THE TREATMENT OF ULCERATIVE COLITIS: OPEN-LABEL, LONG-TERM EXTENSION STUDY
    Bloom, Stuart
    Lichtenstein, Gary R.
    Loftus, Edward V.
    Lawendy, Nervin
    Friedman, Gary S.
    Zhang, Haiying
    Wang, Wenjin
    Thorpe, Andrew J.
    Nduaka, Chudy I.
    Su, Chinyu
    [J]. GUT, 2018, 67 : A62 - A63
12345